Robert Andrade | executive |
Rostislav Raykov | executive |
Adrian Haigh | executive |
Chase Knickerbocker | analyst |
Naureen Quibria | analyst |
Charles Duncan | analyst |
Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2023 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.
Now I would like to turn the conference over to Fennec Chief Financial Officer, Robert Andrade. Please go ahead.
Thank you, operator, and good morning, everyone.